Skip to contentL
Longevity Health Holdings, Inc.
L
XAGELongevity Health Holdings, Inc. Q2 2025 · 10-Q
Revenue$503.61K$503.61K+3,987.8% vs Q2 2024 Net Income-$1.89M-$1.89MN/M vs Q2 2024 EPS Diluted-$1.56-$1.56N/M vs Q2 2024 Gross Profit$302,658+2,416.3% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Longevity Health Holdings, Inc. · CIK 1842939 · Engraved from SEC EDGAR
Operating Cash Flowderived-$836,190N/M Margins · derivedGross margin60.1%−37.5 pt vs Q2 2024
Operating margin-369.1%+9302.1 pt vs Q2 2024
Net margin-374.6%+26448.0 pt vs Q2 2024
ended Jun 30, 2025 · filed Aug 14, 2025 · 45 d after period end